Escalon Medical Corp. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced total revenue was USD 2.898 million compared to USD 2.739 million a year ago. Operating income was USD 103,752 compared to operating loss of USD 672,981 a year ago. Net income was USD 98,476 compared to net loss of USD 675,343 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.09 a year ago. For the half year, total revenue was USD 5.311 million compared to USD 5.027 million a year ago. Operating loss was USD 87,822 compared to USD 806,728 a year ago. Net loss was USD 98,077 compared to USD 53,970 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.